The pilots, developed in partnership with two life insurance companies, are designed to explore how the M-Panel predictive epigenetic technology can be best applied to insurance products and services.  As part of scaling up its operational capabilities, Life Epigenetics has set up a global network of suppliers and test facilities that enable it to analyze tens of thousands of saliva samples per month. And, Life Epigenetics has established research partnerships with two major universities.